|
| |
| | | 58809 | | 16.03.2012 | | Astellas Pharma AG | | | | | | | | | | | | | 07.15. | | | | 07.15. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Advagraf 0.5 mg | Retardkapseln | Delayed release capsules (Tacrolimus 0.5 mg) | L04AD02 | CI | | 02 | Advagraf 1 mg | Retardkapseln | Delayed release capsules (Tacrolimus 1 mg) | L04AD02 | CI | | 03 | Advagraf 5 mg | Retardkapseln | Delayed release capsules (Tacrolimus 5 mg) | L04AD02 | CI | | 04 | Advagraf 3 mg | Retardkapseln | Delayed release capsules (Tacrolimus 3 mg) | L04AD02 | CI |
|
|
|
